The role of cognitive appraisal and worry in BRCA1/2 testing decisions among a clinic population

Psychology and Health

Volumn 22, Issue 6, 2007, Pages 719-736

  Wang, Catharine ^a   Gonzalez, Richard ^b   Janz, Nancy K ^b   Milliron, Kara J ^b,c   Merajver, Sofia D ^b,c  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

Cognitive appraisal; Decision making; Genetic testing; Health belief model; Self regulation; Worry

Indexed keywords

EID: 34547240192     PISSN: 08870446     EISSN: 14768321     Source Type: Journal    
DOI: 10.1080/14768320600976216     Document Type: Article

References (55)

1. Andrykowski, M. A., Lightner, R., Studts, J. L., & Munn, R. K. (1997). Hereditary cancer risk notification and testing: How interested is the general population? Journal of Clinical Oncology, 15, 2139-2148.
2. Becker, M. H., Kaback, M. M., Rosenstock, I. M., & Ruth, M. V. (1975). Some influences on public participation in a genetic screening program. Journal of Community Health, 1, 3-14.
3. Biesecker, B. B., Ishibe, N., Hadley, D. W., Giambarresi, T. R., Kase, R. G., Lerman, C., et al. (2000). Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. American Journal of Medical Genetics, 93, 257-263.
4. Bonadona, V., Saltel, P., Desseigne, F., Mignotte, H., Saurin, J., Wang, Q., et al. (2002). Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: Reactions and behavior after the disclosure of a positive test result. Cancer Epidemiology, Biomarkers & Prevention, 11, 97-104.
5. Bosompra, K., Flynn, B. S., Ashikaga, T., Rairikar, C. J., Worden, J. K., & Solomon, L. J. (2000). Likelihood of undergoing genetic testing for cancer risk: A population-based study. Preventive Medicine, 30, 155-166.
6. Cameron, L. D., & Reeve, J. (2006). Risk perceptions, worry, and attitudes about genetic testing for breast cancer susceptibility. Psychology and Healthy 21, 211-230.
7. Cappelli, M., Surh, L., Humphreys, L., Verma, S., Logan, D., Hunter, A., et al. (1999). Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer. Clinical Genetics, 55, 419-430.
8. Chaliki, H., Loader, S., Levenkron, J. C., Logan-Young, W., Hall, W. J., & Rowley, P. T. (1995). Women's receptivity to testing for a genetic susceptibility to breast cancer. American Journal of Public Health, 85, 1133-1135.
9. Champion, V. L. (1999). Revised susceptibility, benefits, and barriers scale for mammography screening. Research in Nursing and Health, 22, 341-348.
10. Codori, A., Peterson, G. M., Miglioretti, D. L., Larkin, E. K., Bushey, M. T., Young, C., et al. (1999). Attitudes towards colon cancer gene testing: Factors predicting test uptake. Cancer Epidemiology, Biomarkers & Prevention, 8, 345-351.
11. Couch, F. J., DeShano, M. L., Blackwood, A., Calzone, K., Stopfer, J., Campeau, L., et al. (1997). BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. New England Journal of Medicine, 336, 1409-1415.
12. Croyle, R. T., & Lerman, C. (1993). Interest in genetic testing for colon cancer susceptibility: Cognitive and emotional correlates. Preventive Medicine, 22, 284-292.
13. Croyle, R. T., & Lerman, C. (1999). Risk communication in genetic testing for cancer susceptibility. Journal of the National Cancer Institute. Monographs, 25, 59-66.
14. Croyle, R. T., Smith, K. R., Botkin, J. R., Baty, B., & Nash, J. (1997). Psychological responses to BRCA1 mutation testing: Preliminary findings. Health Psychology, 16, 63-72.
15. Diefenbach, M. A., Miller, S. M., & Daly, M. B. (1999). Specific worry about breast cancer predicts mammography use in women at risk for breast and ovarian cancer. Health Psychology, 18, 532-536.
16. Diefenbach, M. A., Schnoll, R. A., Miller, S. M., & Brower, L. (2000). Genetic testing for prostate cancer: Willingness and predictors of interest. Cancer Practice, 8, 82-86.
17. Dorval, M., Patenaude, A. F., Schneider, K. A., Kieffer, S. A., DiGianni, L., Kalkbrenner, K. J., et al. (2000). Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: Findings from p53 and BRCA1 testing programs. Journal of Clinical Oncology, 18, 2135-2145.
18. Durfy, S. J., Bowen, D. J., McTiernan, A., Sporleder, J., & Burke, W. (1999). Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in Western Washington. Cancer Epidemiology, Biomarkers & Prevention, 8, 369-375.
19. Eng, C., Hampel, H., & de la Chapelle, A. (2001). Genetic testing for cancer predisposition. Annual Review of Medicine, 52, 371-400.
20. Folkman, S., Chesney, M., McKusick, L., Ironson, G., Johnson, D. R., & Coates, T. J. (1991). Translating coping theory into an intervention. In J. Eckenrode (Ed.), The social context of coping (pp. 239-260). New York: Plenum Press.
21. Frank, T. S. (1999). Testing of hereditary risk for ovarian cancer. Cancer Control, 6, 327-334.
22. Glanz, K., Grove, J., Lerman, C., Gotay, C., & Le Marchand, L. (1999). Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups. Cancer Epidemiology, Biomarkers & Prevention, 8, 329-336.
23. Gramling, R., Anthony, D., Lowery, J., Ballinger, L., Ma, D., Habbal, R., et al. (2005). Association between screening family medical history in general medical care and lower burden of cancer worry among women with a close family history of breast cancer. Genetics in Medicine, 7, 640-645.
24. Helmes, A. W. (2002). Application of the Protection Motivation Theory to genetic testing for breast cancer risk. Preventive Medicine, 35, 453-462.
25. Jacobsen, P. B., Valdimarsdottir, H. B., Brown, K. L., & Offit, K. (1997). Decision-making about genetic testing among women at familial risk for breast cancer. Psychosomatic Medicine, 59, 459-466.
26. Janz, N. K., Champion, V. L., & Strecher, V. J. (2002). The health belief model. In K. Glanz, B. K. Rimer & F. M. Lewis (Eds), Health behavior and health education (3rd ed., pp. 45-66). San Francisco: Jossey-Bass.
27. Kelly, K., Leventhal, H., Andrykowski, M., Toppmeyer, D., Much, J., Dermody, J., et al. (2004). The decision to test in women receiving genetic counseling for BRCA1 and BRCA2 mutations. Journal of Genetic Counseling, 13, 237-257.
28. Lazarus, R. S., & Folkman, S. (1984). Stress, Appraisal, and Coping. New York: Springer.
29. Lerman, C., Kash, K., & Stefanek, M. (1994). Younger women at increased risk for breast cancer: Perceived risk, psychological well-being, and surveillance behavior. Journal of the National Cancer Institute, Monographs, 16, 171-176.
30. Lerman, C., Narod, S., Schulman, K., Hughes, C., Gomez-Caminero, A., Bonney, G., et al. (1996). BRCA1 testing in families with hereditary breast-ovarian cancer: A prospective study of patient decision making and outcomes. Journal of the American Medical Association, 275, 1885-1892.
31. Lerman, C., Schwartz, M. D., Lin, T. H., Hughes, C., Narod, S., & Lynch, H. T. (1997). The influence of psychological distress on use of genetic testing for cancer risk. Journal of Consulting and Clinical Psychology, 65, 414-420.
32. Lerman, C., Seay, J., Balshem, A., & Audrain, J. (1995). Interest in genetic testing among first-degree relatives of breast cancer patients. American Journal of Medical Genetics, 57, 385-392.
33. Leventhal, H. (1970). Findings and theory in the study of fear communications. In L. Berkowitz (Ed.), Advances in social psychology. New York: Academic Press.
34. Leventhal, H., Leventhal, E. A., & Cameron, L. (2001). Representations, procedures, and affect in illness self-regulation: A perceptual-cognitive model. In A. Baum, T. A. Revenson & J. E. Singer (Eds), Handbook of health psychology (pp. 19-47). New Jersey: Lawrence Erlbaum Associates.
35. Leventhal, H., Safer, M. A., & Panagis, D. M. (1983). The impact of communications on the self-regulation of health beliefs, decisions, and behavior. Health Education Quarterly, 10, 3-29.
36. Lipkus, I. M., Kuchibhatla, M., McBride, C. M., Bosworth, H. B., Pollak, K. I., Siegler, I. C., et al. (2000). Relationships among breast cancer perceived absolute risk, comparative risk, and worries. Cancer Epidemiology, Biomarkers & Prevention, 9, 973-975.
37. Loewenstein, G. F., Weber, E. U., Hsee, C. K., & Welch, N. (2001). Risk as feelings. Psychological Bulletin, 127, 267-286.
38. Lynch, H. T., Lemon, S. J., Durham, C., Tinley, S. T., Connolly, C., Lynch, J. F., et al. (1997). A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer, 79, 2219-2228.
39. Lynch, H. T., Watson, P., Tinley, S., Snyder, C., Durham, C., Lynch, J., et al. (1999). An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer. Cancer Genetics and Cytogenetics, 109, 91-98.
40. Marteau, T. M., & Croyle, R. T. (1998). The new genetics: Psychological responses to genetic testing. British Medical Journal, 316, 693-696.
41. Mellers, B., Schwartz, A., & Ritov, I. (1999). Emotion-based choice. Journal of Experimental Psychology - General, 128, 332-345.
42. Miller, S. M., & Schnell, R. A. (2000). When seeing is feeling: A cognitive-emotional approach to coping with health stress. In M. Lewis & J. M. Haviland-Jones (Eds), Handbook of emotions (pp. 538-557). New York: The Guilford Press.
43. Pasacreta, J. V. (2003). Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: An integrative review. Cancer Investigation, 21, 588-623.
44. Redelmeier, D. A., Rozin, P., & Kahneman, D. (1993). Understanding patients' decisions: Cognitive and emotional perspectives. Journal of the American Medical Association, 270, 72-76.
45. Rogers, R. W. (1983). Cognitive and physiological processes in fear appeals and attitude change: A revised theory of protection motivation. In J. Cacioppo & R. Petty (Eds), Basic social psychophysiological research (pp. 153-176). New York: Guilford Press.
46. Ronis, D. L. (1992). Conditional health threats: Health beliefs, decisions, and behaviors among adults. Health Psychology, 11, 127-134.
47. Ropka, M. E., Wenzel, J., Phillips, E. K., Siadaty, M., & Philbrick, J. T. (2006). Uptake rates for breast cancer genetic testing: A systematic review. Cancer Epidemiology, Biomarkers & Prevevention, 15, 840-855.
48. Shiloh, S., & Ilan, S. (2005). To Test or Not To Test? Moderators of the Relationship Between Risk Perceptions and Interest in Predictive Genetic Testing. Journal of Behavioral Medicine, 28, 467-479.
49. Shiloh, S., Petel, Y., Papa, M., & Goldman, B. (1998). Motivations, perceptions and interpersonal differences associated with interest in genetic testing for breast cancer susceptibility among women at high and average risk. Psychology and Health, 13, 1071-1086.
50. Tessaro, I., Borstelmann, N., Regan, K., Rimer, B. K., & Winer, E. (1997). Genetic testing for susceptibility to breast cancer: Findings from women's focus groups. Journal of Women's Health, 6, 317-327.
51. Wang, C., Gonzalez, R., & Merajver, S. D. (2004). Assessment of genetic testing and related counseling services: Current research and future directions. Social Science and Medicine, 58, 1427-1442.
52. Wang, C., Gonzalez, R., Milliron, K., Strecher, V. J., & Merajver, S. D. (2005). Genetic counseling for BRCA1/2: A randomized controlled trial of two strategies to facilitate the education and counseling process. American Journal of Medical Genetics, 134A, 66-73.
53. Weinstein, N. D. (2000). Perceived probability, perceived severity, and health-protective behavior. Health Psychology, 19, 65-74.
54. Welkenhuysen, M., Evers-Kiebooms, G., Decruyenaere, M., Claes, D., & Denayer, L. (2001). A community based study on intentions regarding predictive testing for hereditary breast cancer. Journal of Medical Genetics, 38, 540-547.
55. Williams-Piehota, P., Pizarro, J., Schneider, T. R., Mowad, L., & Salovey, P. (2005). Matching health messages to monitor-blunter coping styles to motivate screening mammography. Health Psychology, 24, 58-67.